CHUC Charlie’s Holdings
BEST Nicotine Vape Stock

Charlie’s Holdings OTCQB: CHUC Articles

• IKE Tech and Charlie’s Holdings Partner for FIRST US vape age gating system
• Best Profitable Penny Stock for 2026
• Best Profitable Penny Stock with Insider Buying
• CHUC Launches SBX Delivers 336% Q3 Revenue Growth

U.S. Vape Filling Operation Could Double Charlie’s Sales Forecast in 2026

With state of the art equipment and highly trained staff, Charlie’s has opened a dometsic manufaturing facility exclusively for the production of Charlie’s own brands.

Charlie’s launched its own US-filling operation to ensure that the company’s products meet stringent domestic manufacturing requirements of Texas and other large states.

Texas is the largest vapor products market in the United States.

“Demand is so great, we now plan to devote 100% of our current US manufacturing capacity to the the state of Texas; if all goes well, and if we expand our US manufacturing initiative in the coming months, we believe Texas could double Charlie’s sales forecasts for 2026“ 

Profitable Penny Stock With Insider Buying

Dec 17, 2025 President Henry Sicignano buys 100k at $0.21 link

Sept 3, 2025 Director Edward Carmines buys 44k shares avg $0.30 link

August 25, 2025 Director offers very favorable $2 million credit facility link

Management and Founders own approximately 45% link 

One of the Largest PMTA Submitted synthetic nicotine product portfolios

CHUC has a portfolio of 650+ PMTAs, primarily for flavored products. The company believes these PMTAs, as a stand alone asset have an imputed value of over $650MM.

These PMTAs offer Big Tobacco companies a “shortcut” and “legal backdoor into flavored vapor sales, saving tens of millions in compliance, testing and development costs.

The company looks to secure strategic partnerships or licensing deals with other Big Tobacco players and Chinese manufacturers looking for a compliant path into the US market.

Big Tobacco Player Acquires CHUC PMTAs

Into Q3 2025, Charlie’s sold sixteen (16) of the Company’s PACHA synthetic nicotine PMTA products and related assets to one of the world’s largest tobacco companies.

The sale price, in three separate transactions, was $7.5MM, plus a contigent payment of up to $4.2 MM.

This gives an imputed value of CHUC’s PMTA portfolio of over $650MM

R.J. Reynolds Acquires Vape PMTAs from Charlie’s Holdings

BAT Subsidiary Acquires Three More CHUC E-Cigarette Products

RJ Reynolds Third Round Deal: $1 Million Acquisition of PMTA

Reynolds set to launch a new vaping product

What Could CHUC PMTAs Really Be Worth?

We think the market is missing the BIG PICTURE with PMTA products portfolio.

When CHUC was struggling financially, management loaned the company money and they also SOLD 16 of their PMTAs (last one for $1M) to build up working capital…they weren’t in a position to negotiate.

With each PMTA sale, the company’s financial position improved, and the average sale price per PMTA went up.

The last sale gives an imputed value of their portfolio of $679MM (approx $1MM X 679)…BUT here is what market hasn’t priced in.

The market is NOT FACTORING is the possible recurring licensing revenue opportunity of those 679 PMTAs.

On April 16, 2025 Charlies sold 12 PMTAs to “Big Tobacco” which included a one time contingent payment of up to $4.2MM (almost as much as the sale price) for just ONE YEAR following the first day of commercialization.

Now that the company is in much better financial shape, there should be a greater incentive to SELL each PMTA WITH a licensing deal.

A licensing deal could be 5% (industry standard) on future sales of the PMTA going forward.

So…the market should not ONLY look at the imputed value of $679MM but also consider what a possible  recurring revenue stream could look like as well.

Maybe that’s why President Henry Sicignano said in a recent interview, “hopefully to a market cap well north of $1 billion”

Will Big Tobacco Be Forced To Acquire CHUC?

Here is a summary on why Big Tobacco may be forced to acquire CHUC in order to overcome Chinese Tariffs, FDA crackdowns, new state laws and age verification for vaping industry.

Is CHUC Big Tobacco’s SECRET Vape Buyout?

NEW CEO Prepares Company for MAJOR TRANSACTION

​Charlie’s Restructures Executive Team to Shop Proprietary Vape Tech to Global Tobacco Buyers 

Henry Sicignano becomes the new CEO of CHUC… What this really means.

This is not a standard routine executive reshuffle. It is a strategic pivot designed to prepare Charlie’s Holdings for a major transaction.

Sicignano takes the wheel to manage operations and FDA relations, freeing up major shareholder Ryan Stump to shop Charlie’s PMTA portfolio to global tobacco companies, as enhanced by the patented age-gating technology licensed from IKE Tech.

The company has stated numerous times that it believes its PMTA portfolio (before the age-gating launch and/or amending to include age-gating) could be worth many multiples of the current market cap.

This press release signals a dual strategic transition: the company is separating its day-to-day operations from its high-stakes M&A/licensing strategy, effectively positioning itself to be acquired or partnered with Big Tobacco.

1. Skin in the Game: By explicitly noting that Stump and his family control ~30% of the equity (with 10% directly under his name), the press release reassures investors that the guy negotiating the deal has a massive financial incentive to maximize shareholder value.

2. The Mission: Stump’s sole focus is now monetization, selling or licensing Charlie’s 678 PMTA SKUs to a major global tobacco player (e.g., Altria, Philip Morris International, British American Tobacco/R.J. Reynolds, or Japan Tobacco)

3. The “Clean House” Setup: Sicignano’s job as CEO is to run the core business, navigate the FDA regulatory hurdles, and present a clean, attractive asset for potential acquirers or strategic partners.

4. Solving the FDA’s Biggest Headache: The FDA’s primary objection to flavored disposable vapes is youth access. Charlie’s believes that by integrating Device Access Restrictions (DAR) via IKE Tech’s patented age-gating technology, they can prove to the FDA that kids cannot activate their PACHA products.

5. The Trojan Horse: If this commercial rollout proves that age-gating stops underage use in real-world data, it creates a massive regulatory moat. 

It gives Charlie’s a unique bargaining chip that none of the giant legacy tobacco companies currently have in the flavored disposable space.

The Valuation Goal: “$1–2 Billion Market Cap”

• The Math: Stump’s quote setting a $1–2 billion valuation target if they achieve regulatory acceptance on even a fraction of the line is a clear anchor for upcoming transaction talks.
• M&A Target: Big Tobacco lacks legally compliant, youth-protected, flavored disposable products in the U.S. Market. Rather than spending years developing their own technology or fighting FDA rejections, a global tobacco giant could simply acquire or partner with Charlie’s to take over their PMTA portfolio and age-gating framework.

Source  https://www.bamsec.com/filing/143774926025735?cik=1134765

Charlie’s Holdings: 30 PACHA Vape SKUs Identified for FDA Enforcement Discretion

Big Tobacco doesn’t just need another flavored vape.

It needs flavored products that can survive the FDA’s regulatory gauntlet.

That distinction may have transformed Charlie’s Holdings from a small vape company into a potentially invaluable strategic target.

CHUC has spent years — and millions of dollars — building a portfolio of 678 timely-filed PMTAs. In April 2025, one of the world’s largest tobacco companies demonstrated that these regulatory assets have real value by purchasing and licensing 16 PMTAs from Charlie’s for up to $11.7 million, including approximately $1 million in cash outright, for the last SKU purchased. 

This transaction alone suggests that Charlie’s remaining 678 PMTA products could have a value of more than half a BILLION dollars… But what happened next may be even more important.

Regulatory uncertainty forced Big Tobacco to pause the launch of its own flavored disposable. But only one year later, the FDA actually authorized the first fruit-flavored, age-gated vaping products and announced a new enforcement policy for certain other products with officially accepted and filed PMTAs.

As a result, 30 CHUC PACHA SKUs have been identified for inclusion on the FDA’s planned public-facing  list of products that the Agency generally does not intend to prioritize for enforcement.

That is not FDA approval. But in a market filled with illegal flavored products and regulatory uncertainty all around, this major development could give Charlie’s something every major tobacco company needs:

A potentially faster, lower-risk pathway back into the enormous flavored disposable market.

The following timeline shows how a collection of regulatory filings may have evolved into a strategically valuable acquisition portfolio.

Starting in March 2025, CHUC announced that the Center for Tobacco Products of the U.S. Food and Drug Administration (“FDA”) informed the Company that eleven (11) of Charlie’s best-selling flavored PACHA Disposables Pre-Market Tobacco Applications (“PMTAs”) had received Acceptance Filings.

In April 2025, one of the world’s largest tobacco companies went on a buying spree, purchasing 16 CHUC PMTAs for $11.7MM. The last SKU sold for $1MM… And CHUC still has 678 PMTA products in its coffers!

On September 10, 2025, the FDA launched a major escalation in its crackdown on illegal vapes.

On May 5, 2026, the FDA authorized the marketing of four Glas Inc.’s age-gated electronic nicotine delivery systems (“ENDS”) through the premarket tobacco product application (“PMTA”) pathway. This action marked the FDA’s first authorization of non-tobacco, non-menthol “fruit-flavored” ENDS products 

On May 8, 2026, the U.S. Food and Drug Administration issued updated guidance stating it generally does not prioritize enforcement against unauthorized e-cigarettes and nicotine pouches if they have a pending PMTA that has been officially accepted and filed by the agency. 

On June 23, 2026, the FDA notified Charlie’s that certain of the Company’s PACHA products (30 SKUs) for which PMTAs have been submitted have been tentatively identified for inclusion on the FDA’s public-facing webpage of products for which the FDA generally does not intend to prioritize enforcement of premarket authorization requirements. 

The significance of these 30 PACHA SKUs is not simply that Charlie’s may be able to sell more products.

The larger story is what they could represent to Big Tobacco…

One of the world’s largest Big Tobacco companies already demonstrated its willingness to pay millions for access to Charlie’s PMTA portfolio. It then paused its flavored disposable launch in the wake of regulatory uncertainty. Meanwhile, the FDA opened a potentially important pathway for products with accepted and filed PMTAs, and 30 Charlie’s SKUs have been tentatively identified for inclusion under this new enforcement framework.

Again, this does not constitute FDA authorization, guarantee inclusion on the final list, or protect the products from future enforcement action.

But it may significantly change the strategic calculation.

A major tobacco company could spend years developing new flavored products, conducting research, preparing PMTAs, and waiting for the FDA to process them. Or… it could acquire a company that already controls hundreds of pending applications, has 30 SKUs positioned for potentially lower enforcement priority, and possesses a PMTA portfolio that a major tobacco company has already valued at millions of dollars.

That is why Charlie’s may be worth far more to a strategic buyer than it is as a small, standalone vape company.

The buyer would not simply be acquiring flavors, devices, or revenue.

It could be acquiring an extraordinary regulatory strategic advantage.

And in a market where every month outside the flavored vape category can mean lost customers, lost shelf space, lost revenue, and lost market share, time may be Charlie’s most valuable asset.

SBX Best Selling Non Nicotine Flavored Vape

To mitigate regulatory risk, CHUC entered the nicotine substitue product category with SBX, a proprietary, non nicotine, non tobacco alkaloid for vapor products.

SBX could become a “category killer” for the nicotine vaping space.

It is not made or derived from tobacco and contains no nicotine, the FDA’s Center for Tobacco Products (CTP) does not have jurisdiction to regulate it, providing a “regulatory loophole”

SBX products, have shown strong consumer preference for flavored, nicotine-free alternatives.

Focus groups showed Charlie’s non nicotine SBX Disposables were preferred over Juul tobacco-flavored vapes by a 15:1 margin.

SBX offers many more flavor options, unbeatable tax advantages, and thousands more puffs compared to mass market vapes.

Charlie’s Holdings Launches Highly Disruptive SBX Vape

CHUC Strategic DUAL Approach with Flavored Nicotine 

Here’s the threat to Big Tobacco.

SBX, is becoming the BEST SELLING flavored nicotine vape.

Their award winning flavors are LEGAL across almost all 50 states, not subject to Federal restrictions AND nicotine tax exempt in many states.

While Big Tobacco is having their vapes stopped at the border, banned by FDA and states, CHUC’s SBX has the potential to become the LEADER in the $8B flavored nicotine vape space.

One Big Tobacco player recognized this and purchased 16 of CHUC’s PMTAs in order to legally compete.

So CHUC sits with a flavored vape they can sell legally AND 650+ PMTAs that could enable Big Tobacco to “re-enter” the space. 

Can you see why CHUC could be a Big Tobacco buyout?

US Vape Manufacturing Facility “Filled in the USA”

The U.S. vape device market is almost totally dependent on Chinese manufacturing, meaning the new Trump Administration tariffs raise wholesale costs dramatically for importers and retailers.

New state registry laws outright ban most imported flavored disposable vapes, primarily those manufactured in China, by requiring U.S. filled, FDA registered sourcing.

CHUC plans to roll out a U.S. filled product line by Q4 2025, satisfying these domestic manufacaturing mandates.

In addition to mitigating shipping delays and tariff costs, the US-filled line will enable Charlie’s to meet new domestic manufacturing requirements that have been announced by large states.

Age Gating Technology For Vaping Industry

CHUC is developing patented “age-gating” technology involving biometrics to prevent underage access to vaping products.

This “product of merit” could allow CHUC to sell flavored disposables legally even if the FDA rejects others due to youth adoption risks. This technology, spearheaded by board member Dr. Edward Carmines (a world-renoowned expert in e-cigarettes and PMTA submissions) offers a “multi billion dollar licensing opportunity” for ALL vaping companies (nicotine and marijuana)

Large Management Ownership And Funding

Inisder buying can be a great indicator to see how much faith executives have in a small company, but insider funding and reduced salaries could imply even more.

Management and Founders own 45.3%

Management, Founders and Employees have provided several rounds of funding in the past 3 years and imposed executive salary reductions.

Independent Board Member provides favorable $2 million credit facility